company background image
HMD logo

HeraMED ASX:HMD Stock Report

Last Price


Market Cap







11 Jul, 2024


Company Financials

HMD Stock Overview

Develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel.

HMD fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health5/6

HeraMED Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HeraMED
Historical stock prices
Current Share PriceAU$0.024
52 Week HighAU$0.082
52 Week LowAU$0.012
11 Month Change9.09%
3 Month Changen/a
1 Year Change-69.62%
33 Year Change-89.09%
5 Year Change-87.37%
Change since IPO-86.67%

Recent News & Updates

Recent updates

Shareholder Returns

HMDAU Medical EquipmentAU Market

Return vs Industry: HMD underperformed the Australian Medical Equipment industry which returned 25.8% over the past year.

Return vs Market: HMD underperformed the Australian Market which returned 9.8% over the past year.

Price Volatility

Is HMD's price volatile compared to industry and market?
HMD volatility
HMD Average Weekly Movement26.2%
Medical Equipment Industry Average Movement9.5%
Market Average Movement8.3%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market3.3%

Stable Share Price: HMD's share price has been volatile over the past 3 months.

Volatility Over Time: HMD's weekly volatility has increased from 20% to 26% over the past year.

About the Company


HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus’ heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform.

HeraMED Limited Fundamentals Summary

How do HeraMED's earnings and revenue compare to its market cap?
HMD fundamental statistics
Market capAU$9.83m
Earnings (TTM)-AU$6.66m
Revenue (TTM)AU$596.21k


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HMD income statement (TTM)
Cost of RevenueUS$160.96k
Gross ProfitUS$241.94k
Other ExpensesUS$4.74m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date


Earnings per share (EPS)-0.011
Gross Margin60.05%
Net Profit Margin-1,117.60%
Debt/Equity Ratio38.1%

How did HMD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.